Oxford Nanopore Technologies Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: -0.093x

Oxford Nanopore Technologies Ltd cash flow conversion efficiency. Based on the latest financial reports, Oxford Nanopore Technologies Ltd (ONT) has a cash flow conversion efficiency ratio of -0.093x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-39.40 Million ≈ $-4.79K USD) by net assets (GBX424.10 Million ≈ $51.60K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Oxford Nanopore Technologies Ltd (2012–2025)

Cash flow conversion efficiency of Oxford Nanopore Technologies Ltd from 2012 to 2025. This chart illustrates how Oxford Nanopore Technologies Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Oxford Nanopore Technologies Ltd stock quote for real-time trading data and today's change.

Oxford Nanopore Technologies Ltd Cash Flow Conversion Ratio Explained

Oxford Nanopore Technologies Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Oxford Nanopore Technologies Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oxford Nanopore Technologies Ltd ranked by their cash flow conversion efficiency. Also see ONT market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
PLANETEL SPA
F:0A7
N/A
KC Feed Co. Ltd
KQ:025880
0.125x
Zungwon En-Sys Inc
KQ:045510
0.225x
Holaluz-Clidom S.A
MC:HLZ
0.511x
Madison Pacific Properties Inc.
TO:MPC
0.019x
Fold Holdings, Inc. Class A Common Stock
NASDAQ:FLD
-0.302x
Porn Prom Metal Public Company Limited
BK:PPM
0.008x
Carnegie Clean Energy Ltd
AU:CCE
-0.101x

Annual Cash Flow Conversion Efficiency for Oxford Nanopore Technologies Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Oxford Nanopore Technologies Ltd from 2012 to 2025. Review free cash flow generation of Oxford Nanopore Technologies Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 GBX463.30 Million
≈ $56.37K
GBX-62.80 Million
≈ $-7.64K
-0.136x +27.67%
2024-12-31 GBX586.34 Million
≈ $71.34K
GBX-109.89 Million
≈ $-13.37K
-0.187x +12.12%
2023-12-31 GBX643.85 Million
≈ $78.34K
GBX-137.30 Million
≈ $-16.71K
-0.213x -199.47%
2022-12-31 GBX693.56 Million
≈ $84.39K
GBX-49.39 Million
≈ $-6.01K
-0.071x +6.87%
2021-12-31 GBX703.98 Million
≈ $85.65K
GBX-53.83 Million
≈ $-6.55K
-0.076x +77.72%
2020-12-31 GBX185.93 Million
≈ $22.62K
GBX-63.81 Million
≈ $-7.76K
-0.343x +22.79%
2019-12-31 GBX109.53 Million
≈ $13.33K
GBX-48.68 Million
≈ $-5.92K
-0.444x -14.41%
2018-12-31 GBX142.89 Million
≈ $17.39K
GBX-55.51 Million
≈ $-6.75K
-0.388x +45.20%
2017-12-31 GBX93.58 Million
≈ $11.39K
GBX-66.34 Million
≈ $-8.07K
-0.709x -101.08%
2016-12-31 GBX145.24 Million
≈ $17.67K
GBX-51.21 Million
≈ $-6.23K
-0.353x -6.91%
2015-12-31 GBX100.48 Million
≈ $12.23K
GBX-33.14 Million
≈ $-4.03K
-0.330x +35.73%
2014-12-31 GBX66.02 Million
≈ $8.03K
GBX-33.88 Million
≈ $-4.12K
-0.513x -45.03%
2013-12-31 GBX65.77 Million
≈ $8.00K
GBX-23.27 Million
≈ $-2.83K
-0.354x +16.95%
2012-12-31 GBX49.94 Million
≈ $6.08K
GBX-21.27 Million
≈ $-2.59K
-0.426x --

About Oxford Nanopore Technologies Ltd

LSE:ONT UK Biotechnology
Market Cap
$24.48 Million
GBX201.17 Billion GBX
Market Cap Rank
#24263 Global
#232 in UK
Share Price
GBX205.80
Change (1 day)
+0.49%
52-Week Range
GBX104.50 - GBX235.00
All Time High
GBX716.00
About

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version… Read more